Why Dose Timing Matters: Half-Lives and Peak/Trough Dynamics

Testosterone isn't a single molecule with uniform behavior. The ester attached to it — cypionate, enanthate, propionate, or undecanoate — determines how quickly it releases into circulation and how long it stays active. The half-life of the ester is the foundation of every intelligent TRT scheduling decision.

Testosterone cypionate (the most common TRT ester in the US) has a half-life of approximately 8 days. That means after one injection, half of the active testosterone is cleared in 8 days, half of what remains is cleared in the next 8 days, and so on. Testosterone enanthate is nearly identical at 7–8 days. Testosterone propionate clears in 2–3 days. These numbers aren't trivia — they dictate your injection frequency, your peak and trough timing, and ultimately the hormonal environment your athlete trains in.

The peak is the highest serum testosterone level in a cycle, typically 24–72 hours post-injection depending on the ester. The trough is the lowest level, right before the next scheduled injection. The gap between peak and trough is your variability window — and for athletes, that variability matters.

A weekly cypionate injection at 200 mg produces a peak that may reach 1,200–1,500 ng/dL and a trough that can drop below 400 ng/dL. That's a 3–4x swing in testosterone levels across a single week. Energy levels, libido, mood, training motivation, and recovery capacity all shift with that curve. Athletes often don't recognize they're working against their own hormone cycle — they chalk up poor Friday sessions to bad sleep rather than recognizing they're training at trough.

Injection Protocols: Weekly vs. Bi-Weekly vs. EOD

Three protocols dominate TRT in practice. Each makes different tradeoffs between convenience, stability, and optimization potential.

Weekly Injection (Once per Week) Simplest

The most common starting protocol. One injection per week of the full dose. Easy to adhere to, minimal injection burden, but creates the widest peak-to-trough swing of all three options.

Typical Dose
100–200 mg/week
Peak/Trough Swing
High (2–4x variance)
Best For
New patients, compliance-first
Aromatization Risk
Elevated near peak

Athlete consideration: Schedule high-intensity training days 2–4 days post-injection when testosterone is near peak. Avoid testing max lifts at trough. Weekly logs are essential to recognize performance patterns linked to injection timing.

Twice-Weekly (E3.5D) Most Common

Split the weekly dose into two equal injections every 3.5 days. Cuts peak-to-trough variance roughly in half vs. weekly. The standard recommendation for athletes because it balances stability against injection frequency.

Typical Dose
50–100 mg per injection
Peak/Trough Swing
Moderate (1.5–2x variance)
Best For
Most athletes on TRT
Aromatization Risk
Lower than weekly

Athlete consideration: Monday/Thursday or Sunday/Wednesday are common split days. Serum levels are meaningfully more stable, E2 spikes are blunted, and most athletes report mood and energy consistency that weekly injections don't achieve.

Every-Other-Day (EOD) Micro-Dosing Highest Stability

Inject a small dose every 48 hours. Produces the most stable serum testosterone levels — essentially replicating a steady-state concentration. High injection burden but the gold standard for hormonal stability in competitive athletes.

Typical Dose
20–40 mg per injection
Peak/Trough Swing
Minimal (<1.3x variance)
Best For
Competitive athletes, high E2 converters
Aromatization Risk
Lowest

Athlete consideration: EOD works best with short-ester testosterone (propionate) or as a sub-q protocol. Athletes who convert testosterone to estradiol aggressively often find EOD eliminates the need for AI (aromatase inhibitor) entirely because peak levels never reach the aromatization threshold.

What to Track at Every Injection

An injection log that records only "I injected" is nearly worthless for optimization. The data that makes TRT management meaningful requires capturing five dimensions at every injection event.

Injection Log — Required Fields

  • Dose (exact amount in mg) — Not the vial concentration, not an estimate. The precise mg injected. Protocol adjustments depend on this being accurate.
  • Injection time — Hour and day. Peak and trough calculations require knowing exactly when the dose went in. "Monday morning" is not precise enough for correlation analysis.
  • Injection site — Glute (left/right), quad (left/right), deltoid (left/right), sub-q abdomen. Site rotation prevents scar tissue buildup and ensures consistent absorption. You can't rotate if you don't track where you've been.
  • Subjective symptoms at injection time — Energy level, sleep quality, mood, libido. A 1–5 scale is enough. These symptom logs become the leading indicators that precede bloodwork findings.
  • Training performance that day — Not detailed, just a marker: PR, strong session, average, below average. Over 6–8 weeks, the correlation between injection timing and training output becomes visible.

Most athletes skip 3–5 of these fields. Then they ask why they can't figure out why their performance varies. The data isn't in their head — it needs to be in a system.

Key Bloodwork Markers for TRT Athletes

Bloodwork is not optional for athletes on TRT. It is the feedback loop that tells you whether the protocol is working, whether it's becoming dangerous, and where to adjust. Every TRT athlete should have a baseline panel before starting and repeat labs at 6–8 weeks after any protocol change.

Marker Why It Matters Target Range (TRT) Action Threshold
Total Testosterone Overall T level — the primary efficacy marker for TRT 600–900 ng/dL (mid-cycle) Below 400 = under-dosed; above 1,200 = over-dosed
Free Testosterone Bioavailable T not bound to SHBG or albumin — what actually reaches tissues 15–25 pg/mL Low free T despite high total T = SHBG problem
Estradiol (E2) Testosterone converts to E2 via aromatase. Too high = water retention, mood swings, gyno risk. Too low = joint pain, low libido, poor recovery 20–40 pg/mL >60 pg/mL = aromatization concern; <15 pg/mL = crashed (often from AI overuse)
Hematocrit TRT stimulates red blood cell production. Elevated hematocrit increases blood viscosity and cardiovascular risk 40–50% >52% = serious concern; consider therapeutic phlebotomy, reduce dose
SHBG (Sex Hormone Binding Globulin) Binds testosterone in circulation — high SHBG means less free T. SHBG levels determine optimal injection frequency 20–40 nmol/L High SHBG = more frequent injections; low SHBG = EOD is often preferable
PSA (Prostate-Specific Antigen) Required safety marker for males over 40 on TRT. Monitors prostate health <2.5 ng/mL (<40), <4.0 ng/mL (>40) Any rapid increase (0.75+ ng/mL/year) = urgent physician review
Liver Enzymes (AST/ALT) Injectable testosterone has minimal hepatic impact vs. oral androgens, but baseline and periodic monitoring is standard practice AST <40 U/L; ALT <56 U/L 3x upper limit = stop protocol, consult physician
CBC (Complete Blood Count) Full blood panel including hemoglobin, RBC count, platelets. Broader hematological picture beyond hematocrit alone Standard reference ranges Hemoglobin >17.5 g/dL or RBC >6.0 million/mcL = dose review

Testing Frequency

Baseline: Before starting or changing protocol.

Week 6–8: After any dose or frequency change — when serum levels reach steady state.

Ongoing: Every 3–6 months once stable. Hematocrit and PSA should be checked at minimum every 6 months in males over 40.

Timing matters: Draw blood at trough (morning of injection day, before injecting) for the most reproducible result. Mid-cycle or peak draws produce artificially inflated readings that make protocols look more aggressive than they are.

How Coaches Manage Multiple Athletes on Different HRT Protocols

A coach managing 10–15 athletes is not managing 10–15 generic training programs. They're managing 10–15 hormonal environments that each interact with training load, recovery, peptide stacks, and competition schedules differently. This is the coordination problem that makes HRT coaching genuinely difficult at scale.

Consider the complexity: Athlete A is on weekly cypionate at 200 mg, currently 4 days post-injection (near peak, elevated E2 risk). Athlete B is on EOD propionate, no AI. Athlete C just had a dose increase 3 weeks ago and is due for 6-week bloodwork. Athlete D reported mood changes two weeks ago that haven't resolved. All of them train with you this week.

Managing this in a spreadsheet or, worse, from memory is how errors happen. The coordination problem requires three things from a system:

The Apex coach dashboard is built specifically for this. Each athlete has a protocol timeline that captures injections, dose changes, and bloodwork. The coach view surfaces pending actions — overdue labs, unresolved symptom flags, athletes approaching hematocrit thresholds — across the full roster in a single view.

The Protocol Drift Problem

Athletes self-adjust. They miss injections, shift timing for travel, change doses without telling their coach. Protocol drift is the gap between what was prescribed and what's actually happening. Without a log the athlete controls — not just the coach — protocol drift is invisible. Most "non-responders" aren't non-responding to testosterone; they're non-complying, and the data doesn't exist to prove it either way.

Red Flags: When the Protocol Is Working Against the Athlete

Most TRT problems don't announce themselves with obvious symptoms. They accumulate slowly over weeks until the athlete is underperforming, feels suboptimal, and has no data to understand why. These are the early warning signs that something needs adjusting.

Red Flag Likely Cause First Response
Elevated hematocrit (>52%) Excessive erythropoiesis from supraphysiological T, dehydration, high altitude Hydration check, hematocrit retest in 2 weeks. If persistent: reduce dose, consider therapeutic phlebotomy. Flag for physician review.
E2 spike symptoms (water retention, mood instability, sensitivity) High peak T → high aromatization. More common on weekly vs. EOD protocols Check E2 bloodwork. If >60 pg/mL: increase injection frequency (split dose), review AI use. Do not crash E2 — it causes joint pain and depression.
Mood disruption mid-cycle Trough valleys on weekly injections. E2 fluctuations. Excessively low E2 from AI over-suppression Correlate mood logs against injection calendar. If mood drops consistently days 5–7 post-injection: shift to twice-weekly. Rule out crashed E2.
Sleep disruption (waking at 2–4am, poor sleep quality) E2 elevation, cortisol disruption, REM interference common with supraphysiological peaks Check E2. Consider injecting in the morning rather than evening. EOD protocols often resolve sleep issues that weekly protocols create.
Training performance plateau or regression Protocol mismatch — heavy training falling at trough. Hormonal instability limiting recovery capacity Overlay injection timing with training log. If heavy days cluster near trough: shift injection schedule. If E2 or hematocrit are at threshold: address those first.
Low free T despite normal total T Elevated SHBG binding available testosterone — excess T is sequestered Test SHBG. If elevated: investigate cause (chronic stress, liver issues, thyroid). More frequent injections produce higher free T at equivalent weekly dose.

When to Stop and Refer

Coaches work within scope of practice. These situations require physician consultation, not protocol adjustments:

Hematocrit above 54%  ·  PSA increase >0.75 ng/mL/year  ·  Chest pain or palpitations  ·  Any abnormal cardiac symptoms  ·  AST/ALT above 3x upper limit

Document the flag in the athlete's log and refer. The data you've captured makes the physician's job faster and the athlete safer.

Putting It Together: The Optimization Loop

HRT optimization isn't a one-time protocol decision. It's a feedback loop: inject → track → test → adjust → repeat. The athletes who genuinely dial in their TRT are the ones who close that loop consistently, not the ones who find a "protocol" online and run it unchanged for years.

The cycle looks like this:

  1. Establish baseline bloodwork before starting or changing protocol.
  2. Log every injection — dose, time, site, symptoms, training performance.
  3. Identify your hormonal week — where are your highs, your lows, your energy peaks? Align training intensity accordingly.
  4. Retest at week 6–8 of steady-state. Review total T, free T, E2, hematocrit, SHBG.
  5. Adjust and document the change with a reason. Not "I felt off" — specific: "E2 was 58 pg/mL at 6-week check; splitting dose to twice-weekly to reduce aromatization peak."
  6. Correlate with training data. Did the adjustment change performance? Sleep? Recovery speed?

If you're running peptides alongside TRT — BPC-157, TB-500, or GH secretagogues — the bloodwork panel expands. The peptide bloodwork guide covers the additional markers and how to interpret them alongside your hormonal panel.

Disclaimer

This article is for informational purposes for licensed coaches and informed athletes. TRT and HRT protocols require physician oversight and prescription. All protocols should be reviewed by a qualified physician before implementation. Coaches should work within their scope of practice.

Track Every Injection. Monitor Bloodwork Trends. Manage Every Athlete.

Track every injection, monitor bloodwork trends, and manage athlete protocols from one dashboard — try Apex free.

Start Free Trial →